Bharat Biotech International
Fact-checks in which this name appears. A name here says nothing about who made a claim.
Identified as Wikidata Q4901103
Latest fact-checks
13 fact-checks- Falseaccording to Vishvas News17 May 2021Great news, Bharat Biotech's Covaxin (Made in India) has been approved for children over 12 years of age.Machine-translated from Hindi. Original: शानदार खबर, भारत बायोटेक की (मेड इन इंडिया) कोवैक्सीन को 12 साल से अधिक उम्र के बच्चों के लिए मंजूरी मिल गई है।HealthIndia
- Falseaccording to FACTLY12 May 2021Bharat Biotech’s Covaxin received approval to vaccinate children above 12 yearsHealthIndia
- Misleadingaccording to FACTLY11 January 2021190 countries have already pre-booked the Covid vaccine being manufactured in India by Bharat Biotech.Machine-translated from Telugu. Original: భారత దేశంలో భారత్ బయోటెక్ ద్వారా తయారు చేయబడుతున్న కరోనా వాక్సిన్ ని 190 దేశాలు ముందుగానే బుక్ చేసుకున్నాయిHealthIndia
- Misleadingaccording to FACTLY6 January 2021190 countries have pre-booked the Bharat Biotech COVID-19 vaccine that India has developedHealthIndia
- Misleadingaccording to FACTLY10 December 2020The central government has rejected the application seeking permission for emergency use of the coronavirus vaccine being developed by Bharat Biotech.Machine-translated from Telugu. Original: భారత్ బయోటెక్ డెవలప్ చేస్తోన్న కరోనా వ్యాక్సిన్ అత్యవసర వినియోగానికి అనుమతి ఇవ్వాలని చేసిన అప్లికేషన్ ని కేంద్ర ప్రభుత్వం తిరస్కరించిందిHealthIndia
- Falseaccording to FACTLY30 August 2020Vaccine for COVID-19 by Bharat Biotech will be available in the market from 15 August 2020HealthIndia
- Falseaccording to FACTLY30 July 2020The central government gave Bharat Biotech permission to release a Covid vaccine to the market on August 15, 2020.Machine-translated from Telugu. Original: కేంద్ర ప్రభుత్వం భారత్ బయోటెక్ సంస్థ కి కరోనా వాక్సిన్ ని 15 ఆగస్టు 2020న మార్కెట్ లోకి విడుదల చేయడానికి పర్మిషన్ ఇచ్చింది.HealthIndia
- Falseaccording to FACTLY15 July 2020A photo of the Bharat Biotech vice president taking the first dose of Covaxin (the indigenous experimental COVID-19 vaccine).Machine-translated from Kannada. Original: ಭಾರತ್ ಬಯೋಟೆಕ್ ಉಪಾಧ್ಯಕ್ಷರು ಕೋವ್ಯಾಕ್ಸಿನ್ (ದೇಶೀಯ ಪ್ರಾಯೋಗಿಕ ಕೋವಿಡ್-19 ಲಸಿಕೆ) ಮೊದಲ ಡೋಸ್ ತೆಗೆದುಕೊಳ್ಳುವ ಫೋಟೋ.HealthImageIndia
- Falseaccording to Fact Crescendo9 July 2020Bharat Biotech Vice President Dr. V.K. Srinivas, who developed the COVID-19 vaccine, is confidently conducting a clinical trial on his own body with the first dose of the medicine.Machine-translated from Malayalam. Original: കോവിഡ്-19, വാക്സിൻ വികസിപ്പിച്ച ഭാരത് ബയോടെക് വൈസ് പ്രസിഡന്റ് ഡോ.വി.കെ.ശ്രീനിവാസ് ആദ്യഡോസ് മരുന്ന് ആത്മവിശ്വാസത്തോടെ സ്വന്തം ശരീരത്തിൽ …HealthIndia
- Falseaccording to FACTLY6 July 2020As part of the clinical trials of the COVID-19 vaccine made by Bharat Biotech, the company's vice president K.V. Srinivas was the first to test the vaccine on himself.Machine-translated from Telugu. Original: భారత్ బయోటెక్ సంస్థవారు తయారు చేసిన కోవిడ్ -19 వాక్సిన్ క్లినికల్ ట్రయల్స్ లో భాగంగా ఆ సంస్థ వైస్ ప్రెసిడెంట్ కే.వీ.శ్రీనివాస్ మొదట ఆ …HealthIndia
- Falseaccording to Youturn4 July 2020Covaxin is India's first corona vaccine trial, and heartfelt congratulations to Dr. Srinivas, Vice President of Bharat Biotech; let's pray that only good things happen.Machine-translated from Tamil. Original: கோவாக்ஸின் இந்தியாவின் முதல் கொரோனா தடுப்பூசி பரிசோதனை. நெஞ்சார்ந்த நல்வாழ்த்துக்கள் டாக்டர் ஸ்ரீநிவாஸ் சார. பாரத் பயோடெக் துணை தலைவர் …HealthIndia
- Falseaccording to FACTLY4 July 2020Photo of Bharat Biotech Vice President taking COVAXIN (indigenous experimental COVID-19 vaccine) first doseHealthImageIndia
- Falseaccording to The Quint4 July 2020Did a VP of Bharat Biotech take part in the clinical trial of the coronavirus vaccine?Machine-translated from Hindi. Original: क्या भारत बायोटेक के VP ने कोरोना वायरस वैक्सीन का क्लीनिकल ट्रायल लिया?HealthIndia